Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Breast cancer 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
2 Breast cancer 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
3 Breast cancer 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
4 Breast cancer 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
5 Breast cancer 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
6 Breast cancer 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
7 Calcium signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
8 Calcium signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
9 Calcium signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
10 Calcium signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
11 Calcium signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
12 Calcium signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
13 Focal adhesion 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
14 Focal adhesion 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
15 Focal adhesion 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
16 Focal adhesion 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
17 Focal adhesion 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
18 Focal adhesion 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
19 MAPK signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
20 MAPK signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
21 MAPK signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
22 MAPK signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
23 MAPK signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
24 MAPK signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
25 Pathways in cancer 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
26 Pathways in cancer 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
27 Pathways in cancer 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
28 Pathways in cancer 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
29 Pathways in cancer 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
30 Pathways in cancer 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
31 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
32 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
33 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
34 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
35 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
36 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
37 Rap1 signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
38 Rap1 signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
39 Rap1 signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
40 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
41 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
42 Rap1 signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
43 Ras signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
44 Ras signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
45 Ras signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
46 Ras signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
47 Ras signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
48 Ras signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬

Back to top